Member Exclusive News

Novel drug target identified for glioblastoma treatment: breaking the never-ending feedback loop

Targeting the fibroblast growth factor 2 (FGF2) could put an end to the feedback loop involved in the pathogenesis of glioblastoma, suggests researchers from the Cleveland Clinic (OH, USA).

Go to the profile of Harriet Wall
Aug 21, 2019

Please sign in or register for FREE

No comments yet.